# DAPTOMYCIN
> **ANDA213171** · Abbreviated New Drug Application (Generic) · Sponsor: EUGIA PHARMA · Approved 2021-09-02
## Drug
- **FDA Application Number:** ANDA213171
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** DAPTOMYCIN
- **Generic name:** DAPTOMYCIN
- **Active ingredients:** DAPTOMYCIN
- **Dosage form:** POWDER
- **Route:** INTRAVENOUS
- **Marketing status:** Prescription
- **Sponsor:** EUGIA PHARMA
- **Manufacturer:** Eugia US LLC
- **First approval:** 2021-09-02
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=213171)
---
*AI Analytics · CC0 1.0*